Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04234048Phase 1Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Angioimmunoblastic T-cell LymphomaCutaneous T-cell LymphomaCutaneous T-Cell Lymphoma, Unspecified+8 more
PrincipalinvestigatorStart date: 2023-12-18

Research Network

Collaboration Network

10 collaborators·45 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ali Moiin, MD

SciTech Development, Inc.

Very Similar
2 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Auris O Huen, MD, PharmD

M.D. Anderson Cancer Center

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Aaron R Mangold, M.D.

Mayo Clinic

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Barbara Pro, MD

Columbia University

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Jonathan Moreira, M.D.

Northwestern University, Robert H. Lurie Comprehensive Cancer Center

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Brad Haverkos, M.D.

University of Colorado, Denver

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Christiane Querfeld, M.D., Ph.D.

City of Hope Medical Foundation

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Ryan A Wilcox, MD, PhD

University of Michigan

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Dipenkumar Modi, MD

Barbara Ann Karmanos Cancer Institute

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, Peripheral
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04234048Phase 1PrincipalInvestigator

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Angioimmunoblastic T-cell LymphomaCutaneous T-cell LymphomaCutaneous T-Cell Lymphoma, Unspecified+8 more
Recruiting

All 1 trials loaded